Tunicamycin induces paraptosis potentiated by inhibition of BRAFV600Ein FRO anaplastic thyroid carcinoma cells

Anticancer Research

Volumn 34, Issue 9, 2014, Pages 4857-4868

  Kim, Si Hyoung ^a   Shin, Hae Young ^b   Kim, Yong Sun ^a,b   Kang, Jun Goo ^a   Kim, Chul Sik ^a   Ihm, Sung Hee ^a   Choi, Moon Gi ^a   Yoo, Hyung Joon ^a   Lee, Seong Jin ^a  

^a Hallym University College of Medicine   (South Korea)

^b Ilsong Institute of Life Science   (South Korea)

Author keywords

Anaplastic thyroid carcinoma; BRAF; Paraptosis; Tunicamycin

Indexed keywords

B RAF KINASE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLOHEXIMIDE; TUNICAMYCIN; VEMURAFENIB; CASPASE; INDOLE DERIVATIVE; PROTEASOME; SULFONAMIDE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL ACTIVATION; CELL DEATH; CELL STRUCTURE; CELL SURVIVAL; CELL SWELLING; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; ENDOPLASMIC RETICULUM MEMBRANE; HUMAN; PARAPTOSIS; PRIORITY JOURNAL; THYROID CARCINOMA; TRANSMISSION ELECTRON MICROSCOPY; APOPTOSIS; BRAF; DRUG ANTAGONISM; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PROTEIN SYNTHESIS; THYROID TUMOR; TUMOR CELL LINE;

ANAPLASTIC THYROID CARCINOMA; BRAF; PARAPTOSIS; TUNICAMYCIN;

APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; HUMANS; INDOLES; MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS B-RAF; SULFONAMIDES; THYROID NEOPLASMS; TUNICAMYCIN;

EID: 84909981508     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Onoda N, Kashiwagi S, Noda S, Kawajiri H, Takashima T, Ishikawa T and Hirakawa K: High efficacy of chemoradiation therapy sensitized by weekly docetaxel for anaplastic thyroid cancer. Anticancer Res 33: 3445-3448, 2013.
2. Smallridge RC, Marlow LA and Copland JA: Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer 16: 17-44, 2009.
3. Bröker LE, Kruyt FA and Giaccone G: Cell death independent of caspases: a review. Clin Cancer Res 11: 3155-3162, 2005.
4. Jambrina E, Alonso R, Alcalde M, Rodríguez MD, Serrano A, Martínez AC, García-Sancho J and Izquierdo M: Calcium influx through receptor-operated channel induces mitochondria-triggered paraptotic cell death. J Biol Chem 278: 14134-14145, 2003.
5. Fombonne J, Reix S, Rasolonjanahary R, Danty E, Thirion S, Laforge-Anglade G, Bosler O, Mehlen P, Enjalbert A and Krantic S: Epidermal growth factor triggers an original, caspase-independent pituitary cell death with heterogeneous phenotype. Mol Biol Cell 15: 4938-4948, 2004.
6. Fombonne J, Padrón L, Enjalbert A, Krantic S and Torriglia A: A novel paraptosis pathway involving LEI/L-DNasell for EGF-induced cell death in somato-lactotrope pituitary cells. Apoptosis 11: 367-375, 2006.
7. Valamanesh F, Torriglia A, Savoldelli M, Gandolphe C, Jeanny JC, BenEzra D and Behar-Cohen F: Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis. Mol Vis 13: 1746-1757, 2007.
8. Zhang JS, Li DM, Ma Y, He N, Gu Q, Wang FS, Jiang SQ, Chen BQ and Liu JR: γ-Tocotrienol induces paraptosis-like cell death in human colon carcinoma SW620 cells. PLoS One 8: e57779, 2013.
9. Ron D: Translational control in the endoplasmic reticulum stress response. J Clin Invest 110: 1383-1388, 2002.
10. Yorimitsu T, Nair U, Yang Z and Klionsky DJ: Endoplasmic reticulum stress triggers autophagy. J Biol Chem 281: 30299-30304, 2006.
11. Szegezdi E, Logue SE, Gorman AM and Samali A: Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7: 880-885, 2006.
12. Mercer KE and Pritchard CA: Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim Biophys Acta 1653: 25-40, 2003.
13. Xing M: BRAF mutation in thyroid cancer. Endocr Relat Cancer 12: 245-262, 2005.
14. Caronia LM, Phay JE and Shah MH: Role of BRAF in thyroid oncogenesis. Clin Cancer Res 17: 7511-7517, 2011.
15. Nucera C, Nehs MA, Nagarkatti SS, Sadow PM, Mekel M, Fischer AH, Lin PS, Bollag GE, Lawler J, Hodin RA and Parangi S: Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer. Oncologist 16: 296-309, 2011.
16. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC and Haugen BR: Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93: 4331-4341, 2008.
17. Wang WB, Feng LX, Yue QX, Wu WY, Guan SH, Jiang BH, Yang M, Liu X and Guo DA: Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90. J Cell Physiol 227: 2196-2206, 2012.
18. Wang C and Chen T: Intratumoral injection of taxol in vivo suppresses A549 tumor showing cytoplasmic vacuolization. J Cell Biochem 113: 1397-1406, 2012.
19. Yoon MJ, Kang YJ, Lee JA, Kim IY, Kim MA, Lee YS, Park JH, Lee BY, Kim IA, Kim HS, Kim S-A, Yoon A-R, Yun C-O, Kim EY, Lee K and Choi KS: Dimethoxycurcumin stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcumin. Cell Death Differ doi:10.1038/cddis.2014.85, 2014.